First Trust Nasdaq Pharmaceuticals ETF (FTXH)
FTXH is a passive ETF by First Trust tracking the investment results of the Nasdaq U.S. Smart Pharmaceuticals Index. FTXH launched on Sep 20, 2016 and has a 0.60% expense ratio.
ETF Info
US33738R8372
33738R837
Sep 20, 2016
North America (U.S.)
1x
Nasdaq U.S. Smart Pharmaceuticals Index
Multi-Cap
Blend
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in First Trust Nasdaq Pharmaceuticals ETF, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
First Trust Nasdaq Pharmaceuticals ETF had a return of 5.59% year-to-date (YTD) and 14.73% in the last 12 months.
FTXH
5.59%
-2.27%
5.03%
14.73%
6.10%
N/A
^GSPC (Benchmark)
24.72%
1.67%
12.93%
30.55%
13.88%
11.16%
Monthly Returns
The table below presents the monthly returns of FTXH, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 1.33% | 2.82% | 1.25% | -7.21% | 2.22% | 3.03% | 4.80% | 3.87% | -2.34% | -1.97% | 5.59% | ||
| 2023 | 0.36% | -4.47% | -0.37% | 1.92% | -3.91% | 2.92% | 1.33% | 1.26% | -4.58% | -5.97% | 3.91% | 7.05% | -1.41% |
| 2022 | -4.73% | -1.92% | 5.43% | -1.63% | 1.51% | -0.38% | 0.22% | -6.08% | -3.02% | 9.98% | 6.01% | -1.69% | 2.55% |
| 2021 | 1.32% | -1.21% | -0.60% | 1.21% | -0.28% | 0.53% | 1.95% | 1.10% | -3.17% | 1.71% | -2.90% | 6.68% | 6.14% |
| 2020 | -1.89% | -8.36% | -7.00% | 15.06% | 2.09% | 0.03% | 5.27% | 3.26% | -2.50% | -4.48% | 8.66% | 3.37% | 11.73% |
| 2019 | 6.07% | 7.14% | -1.99% | -2.01% | -4.92% | 6.38% | -2.51% | -1.59% | 0.64% | 3.83% | 7.85% | 2.33% | 22.13% |
| 2018 | 5.08% | -3.93% | -2.59% | 0.24% | 1.75% | 1.60% | 5.65% | 3.49% | -0.90% | -7.24% | -0.40% | -11.28% | -9.51% |
| 2017 | 2.29% | 6.72% | -0.71% | 0.32% | -0.50% | 4.78% | -1.69% | -3.60% | 3.91% | -3.60% | 7.83% | 2.93% | 19.44% |
| 2016 | -3.52% | -8.22% | 2.99% | -1.46% | -10.13% |
Expense Ratio
FTXH features an expense ratio of 0.60%, falling within the medium range.
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of FTXH is 40, suggesting that the investment has average results relative to other ETFs in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for First Trust Nasdaq Pharmaceuticals ETF (FTXH) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
First Trust Nasdaq Pharmaceuticals ETF provided a 1.59% dividend yield over the last twelve months, with an annual payout of $0.44 per share. The fund has been increasing its distributions for 4 consecutive years.
| Period | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Dividend | $0.44 | $0.41 | $0.30 | $0.28 | $0.21 | $0.16 | $0.18 | $0.47 | $0.03 |
Dividend yield | 1.59% | 1.56% | 1.10% | 1.03% | 0.82% | 0.67% | 0.92% | 2.18% | 0.19% |
Monthly Dividends
The table displays the monthly dividend distributions for First Trust Nasdaq Pharmaceuticals ETF. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | $0.00 | $0.00 | $0.07 | $0.00 | $0.00 | $0.13 | $0.00 | $0.00 | $0.12 | $0.00 | $0.00 | $0.32 | |
| 2023 | $0.00 | $0.00 | $0.10 | $0.00 | $0.00 | $0.12 | $0.00 | $0.00 | $0.07 | $0.00 | $0.00 | $0.12 | $0.41 |
| 2022 | $0.00 | $0.00 | $0.05 | $0.00 | $0.00 | $0.04 | $0.00 | $0.00 | $0.09 | $0.00 | $0.00 | $0.13 | $0.30 |
| 2021 | $0.00 | $0.00 | $0.08 | $0.00 | $0.00 | $0.05 | $0.00 | $0.00 | $0.04 | $0.00 | $0.00 | $0.11 | $0.28 |
| 2020 | $0.00 | $0.00 | $0.06 | $0.00 | $0.00 | $0.05 | $0.00 | $0.00 | $0.04 | $0.00 | $0.00 | $0.06 | $0.21 |
| 2019 | $0.00 | $0.00 | $0.03 | $0.00 | $0.00 | $0.04 | $0.00 | $0.00 | $0.05 | $0.00 | $0.00 | $0.04 | $0.16 |
| 2018 | $0.00 | $0.00 | $0.08 | $0.00 | $0.00 | $0.04 | $0.00 | $0.00 | $0.03 | $0.00 | $0.00 | $0.04 | $0.18 |
| 2017 | $0.00 | $0.00 | $0.03 | $0.00 | $0.00 | $0.06 | $0.00 | $0.00 | $0.38 | $0.00 | $0.00 | $0.00 | $0.47 |
| 2016 | $0.03 | $0.03 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the First Trust Nasdaq Pharmaceuticals ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the First Trust Nasdaq Pharmaceuticals ETF was 32.11%, occurring on Mar 23, 2020. Recovery took 82 trading sessions.
The current First Trust Nasdaq Pharmaceuticals ETF drawdown is 5.91%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -32.11% | Jan 17, 2020 | 45 | Mar 23, 2020 | 82 | Jul 20, 2020 | 127 |
| -23.42% | Aug 29, 2018 | 76 | Dec 24, 2018 | 254 | Jan 14, 2020 | 330 |
| -14.62% | Jan 30, 2018 | 59 | May 3, 2018 | 53 | Aug 7, 2018 | 112 |
| -14.58% | Dec 5, 2022 | 226 | Oct 27, 2023 | 79 | Feb 22, 2024 | 305 |
| -14.29% | Apr 11, 2022 | 117 | Sep 27, 2022 | 45 | Nov 30, 2022 | 162 |
Volatility
Volatility Chart
The current First Trust Nasdaq Pharmaceuticals ETF volatility is 5.35%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.